August 23, 2011 – In an extensive article reviewing the most popular prostate cancer treatments available to men today, South Florida urologist Bert Vorstman, M.D., takes a critical view on manufacturers, hospital systems and some colleagues who minimize the after effects of radical surgeries while continuing to endorse the procedures as a viable option.

"I believe that the radical surgical/robotic treatment option has single-handedly increased the incidence of impotence and incontinence worldwide, and physicians would do well to consider the Hippocrates affirmation: As to diseases, make a habit of two things – to help, or at least, to do no harm," said Vorstman in his article. "Men who choose these treatments without reviewing alternative, less invasive options are playing Russian Roulette with the quality of life prospects following the surgery."

One in six men in the United States will be diagnosed with prostate cancer in their lifetimes. Vorstman, a nationally recognized prostate cancer specialist with more than 30 years treatment expertise, advocates that men and their partners "do their homework" prior to selecting treatment for prostate cancer that could cause severe, lifelong quality of life issues.

"For some, these issues are worse than the disease itself," Vorstman said.

Today's men have four main definitive treatment options for localized prostate cancer, and these are high-intensity focused ultrasound (HIFU), cryoablation (freezing), radiation and surgical options. In most instances, all of these four treatment options are designed only for localized prostate cancer. The survival benefits are similar, yet the complications, including life-altering impotence or incontinence, vary tremendously between treatments.

"I want patients to realize that prostate cancer is not an emergency diagnosis," Vorstman said. "When we hear the word cancer, we assume fast, aggressive treatment is required. Most prostate cancers are slow growing, which means patients and their partners have time to do their research and make a fully informed decision about treatment. As long as the cancer is not growing aggressively, patients can wait before seeking treatment."

Vorstman urges men and their partners to get very involved in understanding the disease, treatment options and potential complications. "Men should seek written information they can review after their meeting with their doctor. They should also seek several opinions on the various treatment options available. Sadly, there is a lot of questionable information out there, as well as a propensity for medical spin and inflated egos."

The bottom line for patients facing this diagnosis is this, according to Vorstman: "Prostate cancer does not have to be cut out to offer a cure. There are minimally invasive treatments besides surgery that preserve quality of life and give men a better outlook in the future."

For more information: www.hifurx.com/prostate-cancer/prostate-cancer-after-effects/


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiation Oncology

Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...

Time January 13, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
Subscribe Now